Value Chain in the Development of Biomarkers for Disease Targets
Pharmaceutical Sciences Encyclopedia(2010)
摘要
Abstract The continued development of biomarkers and true surrogate markers throughout the drug development value chain in the service of drug registration will remain an important activity to increase efficiency in the drug development process. Academic, pharmaceutical, and regulatory agency partnerships to develop biomarkers collaboratively. This article focuses on biomarker development in preclinical models, in clinical trials, and in partnership with regulatory agencies.
更多查看译文
关键词
Drug Target Identification
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要